Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals

Journal of Clinical Investigation

Volumn 115, Issue 5, 2005, Pages 1210-1220

  Shao, Jian Su ^a   Cheng, Su Li ^a   Pingsterhaus, Joyce M ^a   Charlton Kachigian, Nichole ^a   Loewy, Arleen P ^a   Towler, Dwight A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; BETA GALACTOSIDASE; PARATHYROID HORMONE[1-34]; WNT PROTEIN;

ANIMAL CELL; ARTERY CALCIFICATION; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; DRUG INHIBITION; DRUG MECHANISM; ENZYME INDUCTION; GENE EXPRESSION REGULATION; IMMUNOREACTIVITY; IN VIVO STUDY; LIPID DIET; MOUSE; MYOFIBROBLAST; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUNICA MEDIA;

EID: 18244390222     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI24140     Document Type: Article

References (60)

1. Vattikuti, R., and Towler, D.A. 2004. Osteogenic regulation of vascular calcification: an early perspective. Am. J. Physiol. Endocrinol. Metab. 286:E6S6-E696.
2. Abedin, M., Tintut, Y., and Demer, L.L. 2004. Vascular calcification: mechanisms and clinical ramifications. Arterioscler. Thromb. Vasc. Biol. 24:1161-1170.
3. Moe, S.M., and Chen, N.X. 2004. Pathophysiology of vascular calcification in chronic kidney disease. Circ. Res. 95:560-567.
4. Lehto, S., Niskanen, L., Suhonen, M., Ronnemaa, T., and Laakso, M. 1996. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 16:978-983.
5. London, G.M., et al. 2003. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol. Dial. Transplant. 18:1731-1740.
6. Tintut, Y., et al. 2002. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation. 105:650-655.
7. Zhang, L., et al. 2003. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation. 108:472-478.
8. Bostrom, K., et al. 1993. Bone morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest. 91:1800-1809.
9. Cola, C., Almeida, M., Li, D., Romeo, F., and Mehta, J.L. 2004. Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem. Biophys. Res. Commun. 320:424-427.
10. Cheng, S.L., Shao, J.S., Charlton-Kachigian, N., Loewy, A.P., and Towler, D.A. 2003. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J. Biol. Chem. 278:45969-45977.
11. Rawadi, G., Vayssiere, B., Dunn, F., Baron, R., and Roman-Roman, S. 2003. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J. Bone Miner. Res. 18:1842-1853.
12. Wozney, J.M., and Rosen, V. 1998. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin. Orthop. 346:26-37.
13. Tyson, K.L., et al. 2003. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Artenoscler. Thromb. Vasc. Biol. 23:489-494.
14. Towler, D.A., Bidder, M., Latifi, T., Coleman, T., and Semenkovich, C.F. 1998. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J. Biol. Chem. 273:30427-30434.
15. Schafer, C., et al. 2003, The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J. Clin. Invest. 112:357-366. doi:10.1172/JCI200317202.
16. Rutsch, F., et al. 2001. PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am. J. Pathol. 158:543-554.
17. Speer, M.Y., et al. 2002. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J. Exp. Med. 196:1047-1055.
18. Harmey, D., et al. 2004. Concerted regulation of inorganic pyrophosphate and osceopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am. J. Pathol. 164:1199-1209.
19. Shao, J.S., Cheng, S.L., Charlton-Kachigian, N., Loewy, A.P., and Towler, D.A. 2003. Teriparatide [human parathyroid hormone (1-34)] inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J. Biol. Chem. 278:50195-50202.
20. Satokata, I., et al. 2000. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat. Genet. 24:391-395.
21. Newberry, E.P., Latifi, T., and Towler, D.A. 1998. Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. Biochemistry. 37:16360-16368.
22. Goodwin, A.M., and D'Amore, P.A. 2002. Wnt signaling in the vasculature. Angionesis, 5:1-9.
23. Mao, B., et al. 2002. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature. 417:664-667.
24. Hu, H., et al. 2005. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development. 132:49-60.
25. Davies, M.R., Lund, R.J., and Hruska, K.A. 2003. BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J. Am. Soc. Nephrol. 14:1559-1567.
26. Liu, Y.H., et al. 1995. Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc. Natl. Acad. Sci. U. S. A. 92:6137-6141.
27. Schreyer, S.A., Lystig, T.C., Vick, C.M., and LeBoeuf, R.C. 2003. Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity. Atherosclerosis. 171:49-55.
28. Baskar, J.F., et al. 1996. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J. Virol. 70:3207-3214.
29. van Bezooijen, R.L., et al. 2004. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 199:805-814.
30. Hirschi, K.K., Rohovsky, S.A., and D'Amore, P.A. 1998. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to asmooth muscle fate. J. Cell Biol. 141:805-814.
31. Ross, S.E., et al. 2000. Inhibition of adipogenesis by Wnt signaling. Science. 289:950-953.
32. Boyden, L.M., et al. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346:1513-1521.
33. Kim, K., Pang, K.M., Evans, M., and Hay, E.D. 2000. Overexpression of beta-catenin induces apoptosis independent of its transactivacion function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol. Biol. Cell. 11:3509-3523.
34. Willis, D.M., et al. 2002. Regulation of osteocalcin gene expression by a novel Ku antigen transcription factor complex. J. Biol. Chem. 277:37280-37291.
35. Jono, S., Nishizawa, Y., Shioi, A., and Morii, H. 1997. Parathyroid hormone-related peptide as a local regulator of vascular calcification. Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17:1135-1142.
36. Hussein, S.M., Duff, E.K., and Sirard, C. 2003. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J. Biol. Chem. 278:48805-48814.
37. DasGupta, R., and Fuchs, E. 1999. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development. 126:4557-4568.
38. Ichida, F., et al. 2004. Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. J. Biol. Chem. 279:34015-34022.
39. Willett, J., Epping, M., Pollack, J.R., Brown, P.O., and Nusse, R. 2002. A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev. Biol. 2:8.
40. Hu, Y., et al. 2004. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J. Clin. Invest. 113:1258-1265. doi:10.1172/JCI200419628.
41. Sartore, S., et al. 2001. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ. Res. 89:1111-1121.
42. Heistad, D.D., Marcus, M.L., Larsen, G.E., and Armstrong, M.L. 1981. Role of vasa vasorum in nourishment of the aortic wall. Am. J. Physiol. 240:H781-H787.
43. Bujan, J., et al. 1996. Modifications induced by atherogenic diet in the capacity of the arterial wall in rats to respond to surgical insult. Atherosclerosis. 122:141-152.
44. Lehmann, R., et al. 1980. Alteration of chromatin in early experimental arteriosclerosis. Artery. 8:288-293.
45. Daluiski, A., et al. 2001. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat. Genet. 27:84-88.
46. Fiaschi-Taesch, N., Takane, K.K., Masters, S., Lopez-Talavera, J.C., and Stewart, A.F. 2004. Parathyroid hormone-related protein as a regulator of pRb and the cell cycle in arterial smooth muscle. Circulation. 110:177-185.
47. Slatopolsky, E., et al. 2000. A novel mechanism for skeletal resistance in uremia. Kidney Int. 58:753-761.
48. Sneddon, W.B., et al. 2003. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J. Biol. Chem. 278:43787-43796.
49. Murray, T.M., Rao, L.G., Divieti, P., and Bringhurst, F.R. 2005. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr. Rev. 26:78-113.
50. Tintut, Y., et al. 2003. Multilineage potential of cells from the artery wall. Circulation. 108:2505-2510.
51. Kha, H.T., et al. 2004. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. J. Bone Miner. Res. 19:830-840.
52. Owens, G.K., Kumar, M.S., and Wamhoff, B.R. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84:767-801.
53. Anderson, H.C., et al. 2004. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am. J. Pathol. 164:841-847.
54. Topol, L., et al. 2003. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J. Cell Biol. 162:899-908.
55. Johnson, K., Polewski, M., van Etten, D., and Terkeltaub, R. 2004. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice. Arterioscler. Thromb. Vasc. Biol. doi:10.1161/01.ATV.0000154774.71187-f0.
56. Shao, J.S., Schepp, W., and Alpers, D.H. 1998. Expression of intrinsic factor and pepsinogen in the rat stomach identifies a subset of parietal cells. Am. J. Physiol. 274:G62-G70.
57. Sierra, O.L., Cheng, S.L., Loewy, A.P., Charlton-Kachigian, N., and Towler, D.A. 2004. MINT, the Msx2 interacting nuclear matrix target, enhances Runx2-dependent activation of the osteocalcin fibroblast growth factor response element. J. Biol. Chem. 279:32913-32923.
58. Gregory, C.A., Singh, H., Perry, A.S., and Prockop, D.J. 2003. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J. Biol. Chem. 278:28067-28078.
59. Stratman, J.L., Barnes, W.M., and Simon, T.C., 2003. Universal PCR genotyping assay that achieves single copy sensitivity with any primer pair. Transgenic Res. 12:521-522.
60. Nakashima, K., et al. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 108:17-29.